Format

Send to

Choose Destination
Cell Mol Life Sci. 2004 Sep;61(17):2200-23.

Resistance to beta-lactam antibiotics.

Author information

1
Department of Microbiology and Immunology, Queen's University, K7L 3N6, Kingston, Ontario, Canada. poolek@post.queensu.ca

Abstract

beta-lactams have a long history in the treatment of infectious diseases, though their use has been and continues to be confounded by the development of resistance in target organisms. beta-lactamases, particularly in Gram-negative pathogens, are a major determinant of this resistance, although alterations in the beta-lactam targets, the penicillin-binding proteins (PBPs), are also important, especially in Gram-positive pathogens. Mechanisms for the efflux and/or exclusion of these agents also contribute, though often in conjunction these other two. Approaches for overcoming these resistance mechanisms include the development of novel beta-lactamase-stable beta-lactams, beta-lactamase inhibitors to be employed with existing beta-lactams, beta-lactam compounds that bind strongly to low-affinity PBPs and agents that potentiate the activity of existing beta-lactams against low-affinity PBP-producing organisms.

PMID:
15338052
DOI:
10.1007/s00018-004-4060-9
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center